mirtazapine has been researched along with fluvoxamine in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (43.48) | 29.6817 |
2010's | 9 (39.13) | 24.3611 |
2020's | 4 (17.39) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Demers, JC; Malone, M | 1 |
Anttila, AK; Leinonen, EV; Rasanen, L | 1 |
Dawson, AH; Isbister, GK; Whyte, IM | 1 |
Cornil, C; Dumont, F; Fontaine, E; Machowski, R; Mendlewicz, J; Schittecatte, M; Wilmotte, J | 1 |
Biggio, G; Cherchi, G; Dazzi, L; Seu, E | 1 |
Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
Birkenhäger, TK; Bruijn, JA; Moleman, P; van den Broek, WW; Vulto, AG | 1 |
Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH | 1 |
Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P | 1 |
Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
Abe, M; Egashira, N; Fujiwara, M; Iwasaki, K; Mishima, K; Niki, T; Oishi, R; Shirakawa, A | 1 |
Funaki, Y; Hiraoka, K; Ito, C; Iwata, R; Matsuoka, H; Sato, H; Shibuya, K; Tashiro, M; Yanai, K | 1 |
Li, Y; Lu, X; Tao, C; Yan, W | 1 |
Coffey, BJ; Jaffe, RJ; Juneja, NS | 1 |
Kalisch Ellett, LM; Kassie, GM; Nguyen, TA; Pratt, NL; Roughead, EE | 1 |
Akimoto, H; Asai, S; Hayakawa, T; Minagawa, K; Nagashima, T; Takahashi, Y | 1 |
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
Keidan, L; Pick, CG; Schreiber, S | 1 |
3 review(s) available for mirtazapine and fluvoxamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2010 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
2 trial(s) available for mirtazapine and fluvoxamine
Article | Year |
---|---|
Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed?
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Metabolic Clearance Rate; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome | 2005 |
Histamine H₁ receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers.
Topics: Administration, Oral; Adult; Antidepressive Agents; Area Under Curve; Brain; Chromatography, Liquid; Double-Blind Method; Doxepin; Fluvoxamine; Histamine H1 Antagonists; Humans; Male; Mianserin; Mirtazapine; Positron-Emission Tomography; Receptors, Histamine H1; Sleep Stages; Tandem Mass Spectrometry; Young Adult | 2013 |
18 other study(ies) available for mirtazapine and fluvoxamine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Serotonin syndrome induced by fluvoxamine and mirtazapine.
Topics: Adrenergic alpha-Antagonists; Adult; Adverse Drug Reaction Reporting Systems; Anorexia Nervosa; Drug Interactions; Female; Fluvoxamine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tissue Distribution | 2001 |
Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Interactions; Female; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Male; Mianserin; Mirtazapine | 2001 |
Comment: serotonin syndrome induced by fluvoxamine and mirtazapine.
Topics: Drug Interactions; Fluvoxamine; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2001 |
Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Clonidine; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Mianserin; Mirtazapine; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Sleep, REM | 2002 |
Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress.
Topics: Animals; Antidepressive Agents, Tricyclic; Cerebral Cortex; Cyclohexanols; Electroshock; Extracellular Space; Fluvoxamine; Foot; Male; Mianserin; Microdialysis; Mirtazapine; Neurons; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Venlafaxine Hydrochloride | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.
Topics: Antidepressive Agents; Coitus; Data Interpretation, Statistical; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Mirtazapine; Models, Biological; Piperazines; Reaction Time; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sexual Dysfunction, Physiological; Treatment Outcome; Triazoles | 2008 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
N-acetyl-L-cysteine inhibits marble-burying behavior in mice.
Topics: Acetylcysteine; alpha-Tocopherol; Animals; Antipsychotic Agents; Anxiety Disorders; Behavior, Animal; Fluvoxamine; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Motor Activity; Obsessive-Compulsive Disorder | 2012 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |
Fourteen-Pound Fluvoxamine-Associated Weight Gain in a Young Woman with Depression and Multiple Anxiety Symptoms.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Lamotrigine; Mirtazapine; Obsessive-Compulsive Disorder; Serotonin and Noradrenaline Reuptake Inhibitors; Tic Disorders; Venlafaxine Hydrochloride | 2018 |
The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study.
Topics: Aged; Antidepressive Agents; Australia; Case-Control Studies; Central Nervous System; Citalopram; Delirium; Fluvoxamine; Humans; Mirtazapine; Nitrazepam; Risk Factors; Sertraline; Venlafaxine Hydrochloride | 2022 |
Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies.
Topics: Antidepressive Agents; Cohort Studies; Fluvoxamine; Humans; Hyponatremia; Milnacipran; Mirtazapine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sodium | 2022 |
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Mianserin; Mice; Mirtazapine; Moclobemide; Naloxone; Reboxetine; Trazodone; Venlafaxine Hydrochloride | 2023 |